Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aberrant DNA Methylation”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableUnknownNCT03634826
What this trial is testing

Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).

Who this might be right for
CarcinomaLung CancerNSCLC+1 more
Peking University People's Hospital 200
Not applicableStudy completedNCT01811641
What this trial is testing

Methyl-Donors and EpiGenetics in The Gambia

Who this might be right for
Aberrant DNA Methylation
Medical Research Council 166
Not applicableStudy completedNCT04830618
What this trial is testing

Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms

Who this might be right for
Metachronous NeoplasmGastric CancerGastric Neoplasm+1 more
Seoul National University Hospital 300
Not applicableUnknownNCT02928120
What this trial is testing

Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsAberrant DNA Methylation
Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery 658